title: A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial.
abstract: OBJECTIVE
  To compare repeated doses of sublingual with oral misoprostol in the medical management of early pregnancy failure.
  
  
  METHODS
  One hundred and thirty eight women with a period of gestation less than 20 week calculated by her last menstrual period and less than 12 weeks by size were sequentially allocated to two groups to receive either 400 microg of misoprostol orally or sublingually every 4 hours until termination of pregnancy was completed.
  
  
  RESULTS
  There is no difference in the mean induction to abortion interval. Fever and chill were more common in sublingual group compared with oral group. The other adverse effects were similar and included nausea, vomiting, diarrhea, abdominal pain, and headache.
  
  
  CONCLUSIONS
  Sublingual misoprostol is as effective as oral route. Most adverse effects are similar in both groups except fever was more common in sublingual group.
authors.affiliation: Department of Obstetrics and Gyneacology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Rama 6 Rd, Rachavithee, Bangkok 10400, Thailand.
authors.forename: Orada Patamasingh Na
authors.initials: OP
authors.lastname: Ayudhaya
authors.forename: Yongyoth
authors.initials: Y
authors.lastname: Herabutya
authors.forename: Boonsri
authors.initials: B
authors.lastname: Chanrachakul
authors.forename: Nathpong Israngura Na
authors.initials: NI
authors.lastname: Ayuthaya
authors.forename: Pratak
authors.initials: P
authors.lastname: O-Prasertsawat
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000379:methods*; D000284:Administration, Oral; D000286:Administration, Sublingual; D000328:Adult; D005260:Female; D006801:Humans; D016595:Misoprostol / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications; D013997:Time Factors
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol